APPLICATION
NDA216359
TYPE
NDA
ORIGINAL APPROVAL
2022-08-08
LATEST ACTION
2024-05-02
ROUTE
INTRAMUSCULAR
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) · ReferencePrescription
MIDAZOLAM HYDROCHLORIDE EQ 10MG BASE/0.7ML (EQ 10MG BASE/0.7ML) · SOLUTION · INTRAMUSCULAR
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.